Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019

Azithromycin-nonsusceptible Neisseria gonorrhoeae strains are an emerging global public health threat. During 2015–2018, the prevalence of azithromycin-nonsusceptible gonococcal infection increased significantly in Argentina. To investigate the genomic epidemiology and resistance mechanisms of these...

Full description

Bibliographic Details
Main Authors: Ricardo Ariel Gianecini, Tomas Poklepovich, Daniel Golparian, Noelia Cuenca, Ezequiel Tuduri, Magnus Unemo, Josefina Campos, Patricia Galarza
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-09-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/27/9/20-4843_article
_version_ 1818332310598057984
author Ricardo Ariel Gianecini
Tomas Poklepovich
Daniel Golparian
Noelia Cuenca
Ezequiel Tuduri
Magnus Unemo
Josefina Campos
Patricia Galarza
author_facet Ricardo Ariel Gianecini
Tomas Poklepovich
Daniel Golparian
Noelia Cuenca
Ezequiel Tuduri
Magnus Unemo
Josefina Campos
Patricia Galarza
author_sort Ricardo Ariel Gianecini
collection DOAJ
description Azithromycin-nonsusceptible Neisseria gonorrhoeae strains are an emerging global public health threat. During 2015–2018, the prevalence of azithromycin-nonsusceptible gonococcal infection increased significantly in Argentina. To investigate the genomic epidemiology and resistance mechanisms of these strains, we sequenced 96 nonsusceptible isolates collected in Argentina during 2005–2019. Phylogenomic analysis revealed 2 main clades, which were characterized by a limited geographic distribution, circulating during January 2015–November 2019. These clades included the internationally spreading multilocus sequence types (STs) 1580 and 9363. The ST1580 isolates, which had MICs of 2–4 μg/mL, had mutations in the 23S rRNA. The ST9363 isolates, which had MICs of 2–4 or >256 μg/mL, had mutations in the 23S rRNA, a mosaic mtr locus, or both. Identifying the geographic dissemination and characteristics of these predominant clones will guide public health policies to control the spread of azithromycin-nonsusceptible N. gonorrhoeae in Argentina.
first_indexed 2024-12-13T13:33:43Z
format Article
id doaj.art-dbe732f9f43b4d329a6da95067860080
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-13T13:33:43Z
publishDate 2021-09-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-dbe732f9f43b4d329a6da950678600802022-12-21T23:44:04ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592021-09-012792369237810.3201/eid2709.204843Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019Ricardo Ariel GianeciniTomas PoklepovichDaniel GolparianNoelia CuencaEzequiel TuduriMagnus UnemoJosefina CamposPatricia GalarzaAzithromycin-nonsusceptible Neisseria gonorrhoeae strains are an emerging global public health threat. During 2015–2018, the prevalence of azithromycin-nonsusceptible gonococcal infection increased significantly in Argentina. To investigate the genomic epidemiology and resistance mechanisms of these strains, we sequenced 96 nonsusceptible isolates collected in Argentina during 2005–2019. Phylogenomic analysis revealed 2 main clades, which were characterized by a limited geographic distribution, circulating during January 2015–November 2019. These clades included the internationally spreading multilocus sequence types (STs) 1580 and 9363. The ST1580 isolates, which had MICs of 2–4 μg/mL, had mutations in the 23S rRNA. The ST9363 isolates, which had MICs of 2–4 or >256 μg/mL, had mutations in the 23S rRNA, a mosaic mtr locus, or both. Identifying the geographic dissemination and characteristics of these predominant clones will guide public health policies to control the spread of azithromycin-nonsusceptible N. gonorrhoeae in Argentina.https://wwwnc.cdc.gov/eid/article/27/9/20-4843_articlewhole-genome sequencinggonorrheaazithromycinantimicrobial resistancetreatmentAMR
spellingShingle Ricardo Ariel Gianecini
Tomas Poklepovich
Daniel Golparian
Noelia Cuenca
Ezequiel Tuduri
Magnus Unemo
Josefina Campos
Patricia Galarza
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
Emerging Infectious Diseases
whole-genome sequencing
gonorrhea
azithromycin
antimicrobial resistance
treatment
AMR
title Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
title_full Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
title_fullStr Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
title_full_unstemmed Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
title_short Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
title_sort genomic epidemiology of azithromycin nonsusceptible neisseria gonorrhoeae argentina 2005 2019
topic whole-genome sequencing
gonorrhea
azithromycin
antimicrobial resistance
treatment
AMR
url https://wwwnc.cdc.gov/eid/article/27/9/20-4843_article
work_keys_str_mv AT ricardoarielgianecini genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT tomaspoklepovich genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT danielgolparian genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT noeliacuenca genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT ezequieltuduri genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT magnusunemo genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT josefinacampos genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019
AT patriciagalarza genomicepidemiologyofazithromycinnonsusceptibleneisseriagonorrhoeaeargentina20052019